SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Bitcoins selloff following reports of a major Binance security breach is the main pressure on Strategy, whose shares traders view as closely tied to BTC. The community is split between buying the dip and warning that crypto-security concerns, alongside Strategys revenue miss and CFO transition, could weigh further on the stock.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A run to a fresh 52-week high ahead of the upcoming Q3 report has traders focused on BRIUMVIs sales ramp and managements outlook; some point to earnings expectations, while others speculate about an unconfirmed buyout and short covering.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCaths Medicare add-on reimbursement could fall after the first quarter of 2027 has fueled concerns about CorMedixs pricing and revenue, alongside a sharp selloff. Traders disagree on how much weight to give DaVitas preliminary outlook, with some pointing to CMSs published reimbursement estimate while others see ongoing pressure ahead.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,105,365. The last known price of Bitcoin is 77,177.65528711 USD and is down -1.08 over the last 24 hours. It is currently trading on 12773 active market(s) with $46,266,908,298.36 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

A reported major Binance security breach is driving concern about exchange safety, possible withdrawals and selling pressure across crypto. Traders are divided between expecting further downside from shaken confidence and viewing Bitcoins relative resilience as a buying opportunity, arguing the breach affects the exchange rather than Bitcoins network.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

Energy-sector strength and concern over oil-supply disruptions tied to Middle East tensionsespecially risks to shipping and refiningdominate the discussion around XLE. Traders point to the rally and energys relative strength as bullish, while others warn that diplomatic progress, profit-taking, or an overextended move could weigh on the fund.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

Attention is focused on upcoming Q3 results and the Casgevy sales update, with traders debating whether rising patient starts and treatment-center expansion will translate into stronger collaboration revenue. The upcoming CTX310 clinical presentation is another key catalyst; sentiment is mixed between anticipation of data-driven progress and concern about the stocks decline and CFO transition.

Energy Transfer LP engages in natural gas pipeline transportation and transmission services. It operates through the following segments: Intrastate Transportation and Storage, Interstate Transportation and Storage, Midstream, NGL and Refined Products Transportation and Services, Crude Oil Transportation and Services, Investment in Sunoco LP, Investment in USAC, and All Other. The Intrastate Transportation and Storage segment owns and operates natural gas transportation pipelines. The Interstate Transportation and Storage segment includes transportation pipelines, storage facilities, and gathering systems and delivery of natural gas to industrial end-users and other pipelines. The Midstream segment consists of natural gas gathering, compression, treating, processing, storage, and transportation. The NGL and Refined Products Transportation segment engages in the operations transport, store and execute acquisition, and marketing activities utilizing a complementary network of pipelines, storage and blending facilities, and strategic off-take locations that provide access to multiple NGL markets. The Crude Oil Transportation and Services segment provides transportation, terminalling, acquisition, and marketing services to crude oil markets. The Investment in Sunoco LP segment refers to the distribution of motor fuels to independent dealers, distributors, and other commercial customers and the distribution of motor fuels to end-user customers at retail sites. The Investment in USAC segment offers compression services to its customers in connection with infrastructure applications including both allowing for the processing and transportation of natural gas through the domestic pipeline system and enhancing crude oil production through artificial lift processes. The company was founded by Kelcy L. Warren in 1996 and is headquartered in Dallas, TX.

Energy Transfer LP - Unit

Energy Transfer LP Unit

Energy Transfers strong quarterly results and outlook are fueling discussion of its potential to benefit from rising natural-gas demand for AI data centers and other power customers. Many traders are bullish on that growth and the distribution, while others are frustrated that the unit price has not responded more strongly.

Select Sector SPDR Trust (The) - State Street Technology Select Sector SPDR ETF

Technology Select Sector SPDR Fund

XLK is drawing attention amid a sharp technology-sector selloff, with traders citing broad technical breakdowns and weakness in semiconductors and other tech groups. The conversation is mostly bearish, though some see the pullback as a potential buying opportunity or expect a bounce; confirmation of support remains a key debate.

Amp (AMP) is a cryptocurrency launched in 2020and operates on the Ethereum platform. Amp has a current supply of 99,720,267,351.28921674 with 89,781,193,103.18022 in circulation. The last known price of Amp is 0.0006528 USD and is up 0.85 over the last 24 hours. It is currently trading on 193 active market(s) with $5,174,420.89 traded over the last 24 hours. More information can be found at https://amp.xyz.

AMP Token

A sharp AMP rally and volume spike have traders speculating about renewed interest in the Flexa/Anvil payment-infrastructure thesis and AMPs collateral role. Others say there is no confirmed new catalyst and warn the move may be another short-lived pump.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbases post-earnings selloff is drawing attention as traders weigh weak underlying crypto-trading activity and a revenue shortfall against headline profitability, much of which they attribute to gains on crypto holdings. A Bitcoin slide and Binance hack concerns are adding pressure, though some traders view the decline as an overreaction or buying opportunity.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are Medical Stocks Lagging  Agilon Health (AGL) This Year?

Here is how Agilon Health (AGL) and Arcturus Therapeutics (ARCT) have performed compared to their sector so far this year.

Is Agilon Health (AGL) Stock Outpacing Its Medical Peers This Year?

Here is how Agilon Health (AGL) and CRISPR Therapeutics AG (CRSP) have performed compared to their sector so far this year.

agilon health Sets Date to Report Third Quarter 2026 Financial Results

agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it will release financial results for the third quarter 2026 after market close on Wednesday, November 4, 2026 and host a conference call at 4:30 p.m. ET to...

agilon health and The Jackson Clinic Advance Their Partnership Through Senior Health Connect ACO

agilon health (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced the expansion of its partnership with The Jackson Clinic, which will join one of agilons Senior Health Connect Accountable Care Organizations (ACOs). The Jackson Clinic...

Agilon Health is Now Oversold (AGL)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me...

agilon health and Springfield Clinic Broaden Partnership Through Senior Health Connect ACO

agilon health (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced the expansion of its partnership with Springfield Clinic in Illinois, which will join one of agilons Senior Health Connect Accountable Care Organizations (ACOs...

This Ulta Beauty Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday

Analysts upgraded Pentair, Agilon Health, Etsy, Radiant Logistics and Ulta Beauty, raising or setting new price targets.read more...

agilon health and Family Practice Center Expand Relationship Through Senior Health Connect ACO

agilon health (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced the expansion of its relationship with Family Practice Center, PC (FPC) in Pennsylvania, which will join one of agilons Senior Health Connect Accountable Care...

Is Agilon Health (AGL) Outperforming Other Medical Stocks This Year?

Here is how Agilon Health (AGL) and Illumina (ILMN) have performed compared to their sector so far this year.

agilon health Announces Revised Presentation Time at the 2026 Jefferies Healthcare Services and Technology Conference

agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that its management team will now participate in a fireside chat at the 2026 Jefferies Healthcare Services and Technology Conference at 4:00pm ET on Monday...

Agilon Health, Inc. engages in the provision of healthcare services. It also provides capital, data, payor relationships, executive experience, and contract support that allow physician groups to take on the risk of total care for their patients. The company was founded by Ronald A. Williams and Veeral Desai in 2016 and is headquartered in Westerville, OH.

Agilon Health Inc

AGL Stock's On Track To Hit 9-Month Highs – Here’s Why Analysts And Retail Are Betting On Strong Upside

Equity

Bullish Sentiment

<ul class="summary-bullets"><li>First-quarter revenue came in at $1.42 billion, beating Wall Street’s estimates of $1.38 billion, according to Fiscal.ai data.</li><li>Agilon raised its FY2026 revenue guidance to between $5.68 billion and $5.81 billion, up from its earlier forecast of $5.41 billion to $5.58 billion.</li><li>Jefferies upgraded AGL to ‘Buy’ from ‘Hold’ while increasing its price target by 75% to $48, according to The Fly.</li></ul>Shares of Agilon Health (AGL) surged more than 50% in pre-market trading on Thursday, drawing renewed bullish calls as analysts and investors bet on further upside after the company raised its full-year 2026 guidance and posted a first-quarter earnings beat.<a href="https://stocktwits.com/symbol/AGL">AGL shares</a> are on track to hit their highest levels since August 2025.<h2 class="st-heading-2">Q1 Beat, Raised Guidance, Drive Optimism On AGL Stock</h2>Q1 revenue came in at $1.42 billion, exceeding Wall Street’s estimates of $1.38 billion, according to Fiscal.ai data. Its earnings per share (EPS) of $2.94 far exceeded consensus estimates of $0.93.Agilon raised its FY2026 revenue guidance to between $5.68 billion and $5.81 billion, up from its earlier forecast of $5.41 billion to $5.58 billion. Adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) guidance was raised to between $10 million and $40 million, from the range of a loss of $15 million to a profit of $15 million.<h2 class="st-heading-2">Analysts Flag Strong Potential Upside For AGL Stock</h2>Jefferies upgraded the stock to ‘Buy’ from ‘Hold’ while increasing its price target by 75% to $48, according to The Fly. Analyst Jack Slevin cited “strong” results and “clear signs” of improved trend visibility for the “exceedingly positive” risk/reward set-up of the shares. He added that Agilon’s outlook has been improving as favorable Medicare Advantage rates are now set for 2026 and 2027.Deutsche Bank also upgraded the stock to ‘Buy’ from ‘Hold’ and raised its price target to $49 from $33. The firm said the improving macro environment and “compelling” share valuation were the primary reasons for the upgrade, following Agilon’s guidance raise.<h2 class="st-heading-2">AGL Stock: Retail Sees $100 On The Horizon</h2>Retail sentiment for AGL on Stocktwits flipped to ‘bullish’ from ‘bearish’ a day earlier, while message volumes increased by nearly 260% on the platform.One user said the road to $100 has “officially started.” The stock is currently trading at just below $42.<stembedurl>https://stocktwits.com/Simonyac/message/652554170</stembedurl>Another user highlighted the firm’s improving fundamentals, adding that the company is “definitely turning this around.”<stembedurl>https://stocktwits.com/Loveleaps55/message/652508718</stembedurl>AGL shares have gained around 55% so far in 2026.For updates and corrections, email newsroom[at]stocktwits[dot]com.

AGL shares were in focus on Thursday after receiving bullish brokerage calls following a full-year 2026 guidance raise.

Why Is AGL Stock Rising Today?

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$84.90
Prev Close	$85.94
Open	$84.31
Dividend Yield	0.00%
50-Day Moving Average	$87.87
Beta	0.93
Avg. Volume	217,847.71
PE Ratio	-5.59

52-Week High	$133.04
52-Week Low	$7.48
Market Capitalization	$1.44B
EPS (Annual)	-$24.48
Price to Book	6.26
Revenue Per Employee	$6.93M

Feed

News

Sentiment

Earnings

Fundamentals

Info

AGL Fundamentals